The Mental Elf

Jill Newby talks Transdiagnostic Online CBT at #transdx2018 by The Mental Elf

Research Director of the Global Health Unit at the Norwegian Institute of Public Health, talking about the Informed Health Choices project and Key Concepts for critical thinking about treatment claims.https://en.testingtreatments.org/key-concepts-for-assessing-claims-about-treatment-effects/Lancet papersNsangi A, Semakula D, Oxman A et al.Effects of the Informed Health Choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects: a cluster-randomised controlled trialLancet 2017; 390:374-88https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31226-6/fulltextSemakula D, Nsangi A, Oxman A et al.Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trialLancet 2017; 390:389-98https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31225-4/abstractAn N of 1 trial is a trial with just one person where you randomly decide which treatment is given when. For example, a medicine versus a placebo and you alternate that, usually for up to three times per treatment. The big advantage of this is you find out for that person whether the treatment is helpful or harmful. The limitation of n-of-1-trial isthat you can only use it for diseases that are chronic and stable and where you go more or less go back to the state you were in to begin with after the treatment. So it's good for treatment of symptoms but not fora cure for the disease.GETIT entry: http://www.getitglossary.org/term/single+participant+trial

Hosted on Acast. See acast.com/privacy for more information.

Research Director of the Global Health Unit at the Norwegian Institute of Public Health, talking about the Informed Health Choices project and Key Concepts for critical thinking about treatment claims.

https://en.testingtreatments.org/key-concepts-for-assessing-claims-about-treatment-effects/

Lancet papers

Nsangi A, Semakula D, Oxman A et al.

Effects of the Informed Health Choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects: a cluster-randomised controlled trial

Lancet 2017; 390:374-88

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31226-6/fulltext

Semakula D, Nsangi A, Oxman A et al.

Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trial

Lancet 2017; 390:389-98

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31225-4/abstract

An N of 1 trial is a trial with just one person where you randomly decide which treatment is given when. For example, a medicine versus a placebo and you alternate that, usually for up to three times per treatment. The big advantage of this is you find out for that person whether the treatment is helpful or harmful. The limitation of n-of-1-trial isthat you can only use it for diseases that are chronic and stable and where you go more or less go back to the state you were in to begin with after the treatment. So it's good for treatment of symptoms but not fora cure for the disease.

GETIT entry: http://www.getitglossary.org/term/single+participant+trial

Research Director of the Global Health Unit at the Norwegian Institute of Public Health, talking about the Informed Health Choices project and Key Concepts for critical thinking about treatment claims.

https://en.testingtreatments.org/key-concepts-for-assessing-claims-about-treatment-effects/

Lancet papers

Nsangi A, Semakula D, Oxman A et al.

Effects of the Informed Health Choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects: a cluster-randomised controlled trial

Lancet 2017; 390:374-88

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31226-6/fulltext

Semakula D, Nsangi A, Oxman A et al.

Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trial

Lancet 2017; 390:389-98

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31225-4/abstract

An N of 1 trial is a trial with just one person where you randomly decide which treatment is given when. For example, a medicine versus a placebo and you alternate that, usually for up to three times per treatment. The big advantage of this is you find out for that person whether the treatment is helpful or harmful. The limitation of n-of-1-trial isthat you can only use it for diseases that are chronic and stable and where you go more or less go back to the state you were in to begin with after the treatment. So it's good for treatment of symptoms but not fora cure for the disease.

GETIT entry: http://www.getitglossary.org/term/single+participant+trial

Deputy Director for Applied Research at the Health Experiences Research Group in Oxford talks about Health Talk: a source of free, reliable information about health issues, which features videos of real-life experiences shared by patients.

Hosted on Acast. See acast.com/privacy for more information.

Deputy Director for Applied Research at the Health Experiences Research Group in Oxford talks about Health Talk: a source of free, reliable information about health issues, which features videos of real-life experiences shared by patients.

Deputy Director for Applied Research at the Health Experiences Research Group in Oxford talks about Health Talk: a source of free, reliable information about health issues, which features videos of real-life experiences shared by patients.

Tim Dalgeish answers the burning question: just what is a transdiagnostic approach to psychiatric challenges?

Hosted on Acast. See acast.com/privacy for more information.

Tim Dalgeish answers the burning question: just what is a transdiagnostic approach to psychiatric challenges?

Tim Dalgeish answers the burning question: just what is a transdiagnostic approach to psychiatric challenges?